New drug injection gets first human safety check
NCT ID NCT07171034
Summary
This is an early-stage study to check the safety of a new injectable drug called KLA318-2 in healthy people. Researchers will give the drug to 48 healthy volunteers and closely monitor them for any side effects. The main goal is to see how the body handles the drug and what dose is safe for future testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The first affiliated hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
RECRUITINGJinan, Shandong, 250014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.